What is the official website of MEDICORE LIMITED ?

The official website of MEDICORE LIMITED is http://www.medicore.ua.

What is MEDICORE LIMITED's cybersecurity risk score?

MEDICORE LIMITED has an AI-generated cybersecurity risk score of 800 out of 1000, indicating a Good security posture according to Rankiteo's assessment.

How many security incidents has MEDICORE LIMITED experienced?

According to Rankiteo, MEDICORE LIMITED currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has MEDICORE LIMITED been affected by any supply chain cyber incidents ?

According to Rankiteo, MEDICORE LIMITED has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does MEDICORE LIMITED have SOC 2 Type 1 certification ?

According to Rankiteo, MEDICORE LIMITED is not certified under SOC 2 Type 1.

Does MEDICORE LIMITED have SOC 2 Type 2 certification ?

According to Rankiteo, MEDICORE LIMITED does not hold a SOC 2 Type 2 certification.

Does MEDICORE LIMITED comply with GDPR ?

According to Rankiteo, MEDICORE LIMITED is not listed as GDPR compliant.

Does MEDICORE LIMITED have PCI DSS certification ?

According to Rankiteo, MEDICORE LIMITED does not currently maintain PCI DSS compliance.

Does MEDICORE LIMITED comply with HIPAA ?

According to Rankiteo, MEDICORE LIMITED is not compliant with HIPAA regulations.

Does MEDICORE LIMITED have ISO 27001 certification ?

According to Rankiteo,MEDICORE LIMITED is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does MEDICORE LIMITED operate in ?

MEDICORE LIMITED operates primarily in the Pharmaceutical Manufacturing industry.

How many employees does MEDICORE LIMITED have ?

MEDICORE LIMITED employs approximately 8 people worldwide.

Does MEDICORE LIMITED own any subsidiaries ?

MEDICORE LIMITED presently has no subsidiaries across any sectors.

How many LinkedIn followers does MEDICORE LIMITED have ?

MEDICORE LIMITED's official LinkedIn profile has approximately followers.

What is the NAICS classification code for MEDICORE LIMITED ?

MEDICORE LIMITED is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.

Does MEDICORE LIMITED have a Crunchbase profile ?

No, MEDICORE LIMITED does not have a profile on Crunchbase.

Does MEDICORE LIMITED have a LinkedIn profile ?

Yes, MEDICORE LIMITED maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/medicore-ltd.

How many cybersecurity incidents has MEDICORE LIMITED experienced ?

As of June 8, 2026, Rankiteo reports that MEDICORE LIMITED has not experienced any cybersecurity incidents.

How many peer or competitor companies does MEDICORE LIMITED have ?

MEDICORE LIMITED has an estimated 5,678 peer or competitor companies worldwide.

NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop

WindowsmacOSLinux

Download

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

MEDICORE LIMITED

Boost Score +25 with badge (5 left)

800

/1000

Good

825

/1000

Good

MEDICORE LIMITED Vendor Cyber Rating & Cyber Score

medicore.ua

Add Your Compliance Badge

MEDICORE is one of the leading companies in Ukraine which has been providing logistics services for clinical trials since 2007. MEDICORE provides a full complex of services in clinical trials: from medication import license obtaining and local purchasing to destruction or export services. MEDICORE is a reliable partner in clinical supply chain management in Ukraine that acts in strict compliance with the international laws and local legislation. Over the years, MEDICORE has provided clinical trial logistical services for more than 250 trials, earning a reputation as an established, reliable logistics partner in Ukraine. MEDICORE logistical services are customized to meet the clinical trial warehousing and distribution needs of the

MEDICORE LIMITED A.I CyberSecurity Scoring

Scoring History

MEDICORE LIMITED

MEDICORE LIMITED CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

No data available

Loading…

A.I.

MEDICORE LIMITED Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for MEDICORE LIMITED

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for MEDICORE LIMITED in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for MEDICORE LIMITED in 2026.

Incident Types MEDICORE LIMITED vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for MEDICORE LIMITED in 2026.

Incident History - MEDICORE LIMITED (X = Date, Y = Severity)

Loading…

SUBSIDIARY

MEDICORE LIMITED Subsidiaries

Parent Company

MEDICORE LIMITED

Pharmaceutical Manufacturing

Website: http://www.medicore.ua

Company Size: 51-200 employees

No subsidiary data available for this company.

Loading…

MEDICORE LIMITED Similar Companies

Eli Lilly and Company

lilly.com

We're a medicine company turning science into healing to make life better for people around the world. It all started nearly 150 years ago with a clear vision from founder Colonel Eli Lilly: "Take what you find here and make it better and better." Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing science to solve some of the world's most significant health challenges. General Information and Guidelines: When you engage with us on LinkedIn, you're agreeing to these Community Guidelines: https://e.lilly/guidelines. If you have questions about a Lilly medicine, contact The Lilly Answers Center at 1-800-Lilly-Rx (1-800-545-5979) Monday through Friday, excluding company holidays.

Bristol Myers Squibb

cb bms.com

At Bristol Myers Squibb, we work every day to transform patients’ lives through science. That work inspires some of the most interesting, meaningful, and life-changing careers you’ll experience. Join us and pursue innovative ideas alongside some of the brightest minds in biopharma, collaborating with a team rich in diversity of experiences, and perspectives. We have built a sustainable pipeline of potential therapies and are leveraging translational medicine and data analytics to understand how we can deliver the right medicine to the right patient, at the right time, to achieve the best outcome. Whether in a scientific, business or supporting function, a career at BMS means you’ll be inspired every day to grow and thrive through opportunities that are uncommon in scale and scope. Here, you’ll be on the cutting edge of powerful innovation in oncology, hematology, immunology, cardiovascular disease, and fibrosis, with colleagues united in the mission to help patients. Through the Bristol Myers Squibb Foundation, we also promote health equity and seek to improve health outcomes of populations disproportionately affected by serious diseases and conditions. Our mission is to give new hope to help patients prevail over serious disease – it drives everything we do. Review our Social Media Community Guidelines at: https://www.bms.com/social-media-community-guidelines.html

Viatris

viatris.com

Viatris Inc. (NASDAQ: VTRS) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally. With a mission to empower people worldwide to live healthier at every stage of life, we provide access at scale. In 2022 alone, we supplied high-quality medicines to approximately 1 billion patients around the world. With our exceptionally extensive and diverse portfolio of medicines, a one-of-a-kind global supply chain designed to reach more people when and where they need them, and the scientific expertise to address some of the world’s most enduring health challenges, access takes on deep meaning at Viatris. We have the ability to touch all of life’s moments, from birth to end of life, acute conditions to chronic diseases. We are headquartered in the U.S., with global centers in Pittsburgh, Shanghai and Hyderabad, India Social Media Guidelines: https://newsroom.viatris.com/social-media-community-guidelines Investors: https://investor.viatris.com Corporate Social Responsibility: https://www.viatris.com/sustainability Connect with Viatris Instagram: https://www.instagram.com/viatrisinc X: https://www.x.com/viatrisinc Viatris and our recruiting firms will not ask for sensitive personal information, such as your social security number, date of birth or bank account details via text, email or social media. Additionally, Viatris representatives do not request payment or personal bank information nor send payment to purchase hardware on your own. Viatris.com is the primary source of all company job postings and authorized third-party career websites.

Takeda

cb takeda.com

We strive to transform lives. While the science we advance is constantly evolving, our core purpose is enduring. For more than two centuries, our values have guided us to do what’s right for patients and for society. We know that changing lives requires us to do things differently. We start by listening to and addressing what really matters to patients, the people who love them, and those in the healthcare system who provide care. And that’s what inspires us all to be bold, push boundaries and set new standards that open up greater opportunities. Read our community guidelines: https://takeda.info/communityguidelines

Zydus Group

zyduslife.com

The Zydus Group with an overarching purpose of empowering people with freedom to live healthier and more fulfilled lives, is an innovative, global life-sciences company that discovers, develops, manufactures, and markets a broad range of healthcare therapies. The group employs over 27000 people worldwide and is driven by its mission to unlock new possibilities in life-sciences through quality healthcare solutions that impact lives. The group aspires to transform lives through pathbreaking discoveries.

Johnson & Johnson Innovative Medicine

cb jnj.com

At Johnson & Johnson Innovative Medicine, we innovate with purpose, to lead where medicine is going. The experiences of patients around the world inform and inspire our science-based innovations, which continue to change and save lives. Applying rigorous science with compassion, we confidently address the most complex diseases of our time and develop the potential medicines of tomorrow. We are continuously working to develop treatments, aspiring to find cures, pioneering the path from lab to life, and championing patients every step of the way. https://bit.ly/3reuMvK

AUROBINDO PHARMA LTD

aurobindo.com

Aurobindo Pharma Limited (NSE: AUROPHARMA, BSE: 524804, Reuters: ARBN.NS, Bloomberg: ARBP IN) is an integrated global pharmaceutical company headquartered in Hyderabad, India. The Company develops, manufactures, and markets a wide range of generic pharmaceuticals, branded specialty drugs, and active pharmaceutical ingredients (APIs) across more than 150 countries. It is ranked among the top 10 generic companies in eight European nations and holds the distinction of being the largest generic pharmaceutical company in the United States. With over 30 state-of-the-art manufacturing and packaging facilities approved by leading global regulatory authorities including USFDA, UK MHRA, EDQM, Japan PMDA, WHO, Health Canada, South Africa MCC, and Brazil ANVISA, Aurobindo Pharma ensures the highest standards of quality. Its robust portfolio spans eight major therapeutic areas: Central Nervous System (CNS), Antiretroviral (ARV), Cardiovascular (CVS), Antibiotics, Gastroenterology, Anti-diabetics, Oncology, and Dermatology, supported by a strong R&D infrastructure that drives innovation, affordability, and accessibility.

Catalent

catalent.com

Championing the missions that matter™. Catalent, Inc. is a leading global contract development and manufacturing organization (CDMO) and trusted partner to pharma, biotech, and consumer health companies worldwide. We put patients first in everything we do, helping people live better and healthier lives through every product we help develop, manufacture and deliver. With over 1,000 active development programs at any given time, we launch over 100 new products and line extensions annually. Catalent has supported half of all FDA approvals over the past decade, and our teams working at over 40 global sites help us produce over 60 billion doses every year. Our strength lies in our people: teams across our more than 40 sites and thousands of passionate scientists and technicians who bring expertise in development sciences, delivery technologies, and multi-modality manufacturing. What unites us is our commitment to championing our partners’ missions as our own, anticipating customer needs, solving complex challenges and ultimately making a difference in the lives of patients across the globe. At Catalent, you will be able to directly have an impact, solving problems and ensuring excellence for our customers. Our focus on delivering meaningful outcomes alongside our customers means your work directly impacts millions of people around the world. Join us in championing the missions that matter. Catalent is headquartered in Tampa, Florida, with over 40 global sites. Visit www.catalent.com to learn more.

Merck

merck.us

At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.merck.com. This site is intended for residents of the United States and Canada and their territories only. FLS: http://merck.us/3TKXNuZ

Loading…

NEWS

MEDICORE LIMITED CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-11466

SUMMARY

A weakness has been identified in zilliztech deep-searcher up to 0.0.2. This affects the function CollectionRouter.invoke of the file deepsearcher/agent/collection_router.py. This manipulation of the argument kwargs causes improper access controls. Remote exploitation of the attack is possible. The exploit has been made available to the public and could be used for attacks. The pull request to fix this issue awaits acceptance.

Published

Date2026-06-07

Updated

Date2026-06-07

RISK INFORMATION (Score: 5.4)

cvss2

Base Score: 5.5

Complexity: LOW

AV:N/AC:L/Au:S/C:P/I:N/A:P

cvss3

Base Score: 5.4

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:L

cvss4

Base Score: 2.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:N/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

2.5

Exploitability

2.8

REFERENCES

CVE-2026-11465

SUMMARY

A security flaw has been discovered in songquanpeng one-api up to 0.6.11-preview.7. Affected by this issue is the function Redeem of the file model/redemption.go of the component Redemption Code Top-Up Endpoint. The manipulation results in business logic errors. The attack may be launched remotely. The attack requires a high level of complexity. The exploitation is known to be difficult. The exploit has been released to the public and may be used for attacks. The pull request to fix this issue awaits acceptance.

Published

Date2026-06-07

Updated

Date2026-06-07

RISK INFORMATION (Score: 3.1)

cvss2

Base Score: 2.1

Complexity: HIGH

AV:N/AC:H/Au:S/C:N/I:P/A:N

cvss3

Base Score: 3.1

Complexity: HIGH

CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:U/C:N/I:L/A:N

cvss4

Base Score: 1.3

Complexity: HIGH

CVSS:4.0/AV:N/AC:H/AT:N/PR:L/UI:N/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

1.4

Exploitability

1.6

REFERENCES

CVE-2026-11464

SUMMARY

A vulnerability was identified in JeecgBoot up to 3.9.2. Affected by this vulnerability is the function queryPageList of the file src\main\java\org\jeecg\modules\system\controller\SysUserController.java of the component User List Endpoint. The manipulation of the argument salt leads to information disclosure. The attack may be initiated remotely. The attack is considered to have high complexity. The exploitation appears to be difficult. The exploit is publicly available and might be used. A fix is planned for the upcoming release.

Published

Date2026-06-07

Updated

Date2026-06-07

RISK INFORMATION (Score: 3.1)

cvss2

Base Score: 2.1

Complexity: HIGH

AV:N/AC:H/Au:S/C:P/I:N/A:N

cvss3

Base Score: 3.1

Complexity: HIGH

CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:U/C:L/I:N/A:N

cvss4

Base Score: 1.3

Complexity: HIGH

CVSS:4.0/AV:N/AC:H/AT:N/PR:L/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

1.4

Exploitability

1.6

REFERENCES

CVE-2026-11463

SUMMARY

A vulnerability was determined in USCiLab Cereal up to 1.3.2. Affected is an unknown function of the component Shared Pointer Handler. Executing a manipulation can lead to type confusion. The attack can be launched remotely. The exploit has been publicly disclosed and may be utilized. The vendor was contacted early about this disclosure.

Published

Date2026-06-07

Updated

Date2026-06-07

RISK INFORMATION (Score: 7.3)

cvss2

Base Score: 7.5

Complexity: LOW

AV:N/AC:L/Au:N/C:P/I:P/A:P

cvss3

Base Score: 7.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L

cvss4

Base Score: 2.9

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:P/PR:N/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.4

Exploitability

3.9

REFERENCES

CVE-2026-11462

SUMMARY

A vulnerability was found in Chengdu Everbrite Network Technology BeikeShop up to 1.6.0.22. This impacts the function callback of the file plugins/Stripe/Controllers/StripeController.php of the component Stripe Plugin. Performing a manipulation of the argument Request results in improper authorization. The attack can be initiated remotely. The exploit has been made public and could be used. The patch is named 6719e0fc690ea0a998452092862e0f0a17c65968. It is suggested to install a patch to address this issue.

Published

Date2026-06-07

Updated

Date2026-06-07

RISK INFORMATION (Score: 7.3)

cvss2

Base Score: 7.5

Complexity: LOW

AV:N/AC:L/Au:N/C:P/I:P/A:P

cvss3

Base Score: 7.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L

cvss4

Base Score: 5.5

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.4

Exploitability

3.9

REFERENCES

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…